{"mainPropery":{"diseaseId":6414,"diseaseName":"Familial chylomicronemia syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6414/familial-chylomicronemia-syndrome","synonyms":["Hyperlipoproteinemia type 1"],"synonyms-with-source":[{"name":"Hyperlipoproteinemia type 1","source":"OMIM"}],"identifiers":[{"identifierType":"OMIM","identifierId":"238600"},{"identifierType":"ORPHANET","identifierId":"444490"}]},"diseaseCategories":[{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":917,"resourceName":"American Dietetic Association","address1":"120 South Riverside Plaza, Suite 2000","address2":"","address3":"","address4":"","city":"Chicago","state":"IL","zip":"60606-6995","country":"United States","phone":"","tollFree":"800-366-1655","fax":"","email":"knowledge@eatright.org","url":"http://www.eatright.org/Public/"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/238600' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=238600' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Familial chylomicronemia syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Hyperlipoproteinemia+type+1%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Familial chylomicronemia syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=familiallipoproteinlipasedeficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Familial chylomicronemia syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/lipoprotein-lipase-deficiency' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/tests/?term=238600[mim]&condition=C0023817' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://rarediseases.org/rare-diseases/familial-lipoprotein-lipase-deficiency/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000408.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1214018-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=444490' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=lpl' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_Search_Simple.php?lng=EN&LnkId=3263&Typ=Pat&RchTyp=Rch' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&LnkId=3263&Typ=Pat' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:411' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/hypercholesterolemia' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":2518,"questionText":"What is hyperlipoproteinemia type 1?","answerText":"<strong>Hyperlipoproteinemia type 1</strong>&nbsp;is an inherited condition that disrupts the normal breakdown of fats in the body, causing a large amount of fat to build up in the blood.[1594] This condition is characterized by inflammation of the pancreas (<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000221.htm\" target=\"_blank\">pancreatitis</a>), abdominal pain, enlargement of the liver and spleen (<a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003275.htm\" target=\"_blank\">hepatosplenomegaly</a>), and small yellow skin lesions called eruptive <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/001447.htm\" target=\"_blank\">xanthomas</a>.[1594][1595] Hyperlipoproteinemia type 1 is caused by mutations in the <a class=\"link-dapple\" title=\"L P L\" href=\"http://ghr.nlm.nih.gov/gene=lpl\" target=\"_blank\"><span><em>LPL</em></span></a> gene. This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern.[1594] Treatment aims to control the symptoms through a low-fat diet.[1595]","dateModified":"2016-03-08T00:00:00"},"basicQuestions":[{"questionId":2519,"questionText":"What are the symptoms of hyperlipoproteinemia type 1?","answerText":"<p>The signs and&nbsp;symptoms of hyperlipoproteinemia type 1 usually begin during childhood. Approximately 25 percent of affected individuals develop symptoms before age 1. The characteristic features of hyperlipoproteinemia type 1 include:[1594][1595][1596]</p>\r\n<li>Abdominal pain (may manifest as colic in infancy)\r\n</li>\r\n<li>Nausea, vomiting, loss of appetite\r\n</li>\r\n<li><a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/000991.htm\" target=\"_blank\">Failure to thrive</a> in infancy\r\n</li>\r\n<li>Musculoskeletal pain (pain in the muscles and bones)</li>\r\n<li><a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/001447.htm\" target=\"_blank\">Xanthomas</a> (small, yellow, fat deposits in the skin) </li>\r\n<li><a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000221.htm\" target=\"_blank\">Pancreatitis</a></li>\r\n<li>Enlarged liver and spleen (<a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003275.htm\" target=\"_blank\">hepatosplenomegaly</a>)</li>\r\n<br />\r\nIn some cases, neurological features develop, including depression, memory loss, and mild intellectual decline (dementia). These symptoms typically go away once dietary fat levels are lowered.[1594][1596]&nbsp;<br />","dateModified":"2016-03-08T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1595,"authors":"Martin LJ, Zieve D","articleTitle":"Familial lipoprotein lipase deficiency","bookWebsiteJournalTitle":"MedlinePlus","date":"April 30, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000408.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1596,"authors":"Brunzell JD","articleTitle":"Familial Lipoprotein Lipase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"April 24, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1308/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2520,"questionText":"What causes&nbsp;hyperlipoproteinemia type 1?","answerText":"<p class=\"MsoNormal\" style=\"margin: 0in 0in 0pt;\">Hyperlipoproteinemia type 1 is caused by mutations in the <a class=\"link-dapple\" title=\"L P L\" href=\"https://ghr.nlm.nih.gov/gene/LPL\" target=\"_blank\"><em>LPL</em></a> gene.&nbsp;This&nbsp;<a href=\"http://ghr.nlm.nih.gov/handbook/basics/gene\" target=\"_blank\">gene</a> provides instructions for producing an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=\"_blank\">enzyme</a> called lipoprotein lipase. This enzyme helps break down fats called triglycerides, which are carried by molecules called&nbsp;lipoproteins.[1594]<br />\r\n<br />\r\n<a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/genemutation\" target=\"_blank\">Mutations</a> in the <em>LPL</em> gene lead to a reduction or elimination of lipoprotein lipase activity, which prevents the enzyme from effectively breaking down triglycerides. As a result, triglycerides attached to lipoproteins build up in the blood and tissues, leading to the signs and symptoms of&nbsp;hyperlipoproteinemia type 1.[1594]</p>","dateModified":"2016-03-08T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":1594,"authors":"","articleTitle":"Familial lipoprotein lipase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference Website","date":"February 2015","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/familial-lipoprotein-lipase-deficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2521,"questionText":"What is the treatment for hyperlipoproteinemia type 1?","answerText":"Treatment for hyperlipoproteinemia type 1&nbsp;is intended to control&nbsp;blood <a href=\"http://www.nlm.nih.gov/medlineplus/triglycerides.html\" target=\"_blank\">triglyceride</a> levels with a very low-fat diet. It is recommended that individuals with this condition eat no more than 20 grams of fat per day.[1595] Medium-chain fatty acids (such as coconut oil) can be incorporated into the diet, as they are absorbed by the body in a different manner.&nbsp;Dietary counseling&nbsp;may be helpful to maintain adequate calorie and nutrient intake.[1596]","dateModified":"2016-03-08T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1595,"authors":"Martin LJ, Zieve D","articleTitle":"Familial lipoprotein lipase deficiency","bookWebsiteJournalTitle":"MedlinePlus","date":"April 30, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000408.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1596,"authors":"Brunzell JD","articleTitle":"Familial Lipoprotein Lipase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"April 24, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1308/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":759,"relatedDiseaseName":"Apolipoprotein C-II deficiency","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":12241,"relatedDiseaseName":"Familial lipoprotein lipase deficiency","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":24471,"abbreviatedInquiry":"I was born with hyperlipoproteinemia type 1, and&nbsp;I would like more information on my disease.&nbsp;I have been pretty much on my own due to lack of knowledge by my doctors. ","caseQuestions":[{"questionId":2518,"questionText":"What is hyperlipoproteinemia type 1?","answerText":"<strong>Hyperlipoproteinemia type 1</strong>&nbsp;is an inherited condition that disrupts the normal breakdown of fats in the body, causing a large amount of fat to build up in the blood.[1594] This condition is characterized by inflammation of the pancreas (<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000221.htm\" target=\"_blank\">pancreatitis</a>), abdominal pain, enlargement of the liver and spleen (<a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003275.htm\" target=\"_blank\">hepatosplenomegaly</a>), and small yellow skin lesions called eruptive <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/001447.htm\" target=\"_blank\">xanthomas</a>.[1594][1595] Hyperlipoproteinemia type 1 is caused by mutations in the <a class=\"link-dapple\" title=\"L P L\" href=\"http://ghr.nlm.nih.gov/gene=lpl\" target=\"_blank\"><span><em>LPL</em></span></a> gene. This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern.[1594] Treatment aims to control the symptoms through a low-fat diet.[1595]","dateModified":"2016-03-08T00:00:00","references":[{"referenceId":1594,"authors":"","articleTitle":"Familial lipoprotein lipase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference Website","date":"February 2015","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/familial-lipoprotein-lipase-deficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1595,"authors":"Martin LJ, Zieve D","articleTitle":"Familial lipoprotein lipase deficiency","bookWebsiteJournalTitle":"MedlinePlus","date":"April 30, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000408.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2519,"questionText":"What are the symptoms of hyperlipoproteinemia type 1?","answerText":"<p>The signs and&nbsp;symptoms of hyperlipoproteinemia type 1 usually begin during childhood. Approximately 25 percent of affected individuals develop symptoms before age 1. The characteristic features of hyperlipoproteinemia type 1 include:[1594][1595][1596]</p>\r\n<li>Abdominal pain (may manifest as colic in infancy)\r\n</li>\r\n<li>Nausea, vomiting, loss of appetite\r\n</li>\r\n<li><a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/000991.htm\" target=\"_blank\">Failure to thrive</a> in infancy\r\n</li>\r\n<li>Musculoskeletal pain (pain in the muscles and bones)</li>\r\n<li><a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/001447.htm\" target=\"_blank\">Xanthomas</a> (small, yellow, fat deposits in the skin) </li>\r\n<li><a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000221.htm\" target=\"_blank\">Pancreatitis</a></li>\r\n<li>Enlarged liver and spleen (<a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003275.htm\" target=\"_blank\">hepatosplenomegaly</a>)</li>\r\n<br />\r\nIn some cases, neurological features develop, including depression, memory loss, and mild intellectual decline (dementia). These symptoms typically go away once dietary fat levels are lowered.[1594][1596]&nbsp;<br />","dateModified":"2016-03-08T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1595,"authors":"Martin LJ, Zieve D","articleTitle":"Familial lipoprotein lipase deficiency","bookWebsiteJournalTitle":"MedlinePlus","date":"April 30, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000408.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1596,"authors":"Brunzell JD","articleTitle":"Familial Lipoprotein Lipase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"April 24, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1308/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2520,"questionText":"What causes&nbsp;hyperlipoproteinemia type 1?","answerText":"<p class=\"MsoNormal\" style=\"margin: 0in 0in 0pt;\">Hyperlipoproteinemia type 1 is caused by mutations in the <a class=\"link-dapple\" title=\"L P L\" href=\"https://ghr.nlm.nih.gov/gene/LPL\" target=\"_blank\"><em>LPL</em></a> gene.&nbsp;This&nbsp;<a href=\"http://ghr.nlm.nih.gov/handbook/basics/gene\" target=\"_blank\">gene</a> provides instructions for producing an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=\"_blank\">enzyme</a> called lipoprotein lipase. This enzyme helps break down fats called triglycerides, which are carried by molecules called&nbsp;lipoproteins.[1594]<br />\r\n<br />\r\n<a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/genemutation\" target=\"_blank\">Mutations</a> in the <em>LPL</em> gene lead to a reduction or elimination of lipoprotein lipase activity, which prevents the enzyme from effectively breaking down triglycerides. As a result, triglycerides attached to lipoproteins build up in the blood and tissues, leading to the signs and symptoms of&nbsp;hyperlipoproteinemia type 1.[1594]</p>","dateModified":"2016-03-08T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":1594,"authors":"","articleTitle":"Familial lipoprotein lipase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference Website","date":"February 2015","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/familial-lipoprotein-lipase-deficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2521,"questionText":"What is the treatment for hyperlipoproteinemia type 1?","answerText":"Treatment for hyperlipoproteinemia type 1&nbsp;is intended to control&nbsp;blood <a href=\"http://www.nlm.nih.gov/medlineplus/triglycerides.html\" target=\"_blank\">triglyceride</a> levels with a very low-fat diet. It is recommended that individuals with this condition eat no more than 20 grams of fat per day.[1595] Medium-chain fatty acids (such as coconut oil) can be incorporated into the diet, as they are absorbed by the body in a different manner.&nbsp;Dietary counseling&nbsp;may be helpful to maintain adequate calorie and nutrient intake.[1596]","dateModified":"2016-03-08T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1595,"authors":"Martin LJ, Zieve D","articleTitle":"Familial lipoprotein lipase deficiency","bookWebsiteJournalTitle":"MedlinePlus","date":"April 30, 2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000408.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1596,"authors":"Brunzell JD","articleTitle":"Familial Lipoprotein Lipase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"April 24, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1308/","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13752,"phenoTypeName":"Hypertriglyceridemia","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":6288,"phenoTypeName":"Increased circulating chylomicron concentration","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":3876,"phenoTypeName":"Acute pancreatitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14338,"phenoTypeName":"Episodic abdominal pain","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8125,"phenoTypeName":"Hepatosplenomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10136,"phenoTypeName":"Lipemia retinalis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11469,"phenoTypeName":"Recurrent pancreatitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8293,"phenoTypeName":"Eruptive xanthomas","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5695,"phenoTypeName":"Hepatic steatosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13403,"phenoTypeName":"Nausea and vomiting","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11861,"phenoTypeName":"Abnormal emotion/affect behavior","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6011,"phenoTypeName":"Depressivity","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14182,"phenoTypeName":"Diabetes mellitus","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10276,"phenoTypeName":"Jaundice","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11437,"phenoTypeName":"Memory impairment","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":482,"phenoTypeName":"Perianal abscess","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8074,"phenoTypeName":"Pulmonary embolism","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":14568,"phenoTypeName":"Hypercholesterolemia","percentRanges":"-"},{"phenoTypeId":14535,"phenoTypeName":"Hyperlipidemia","percentRanges":"-"},{"phenoTypeId":1276,"phenoTypeName":"Lactescent serum","percentRanges":"-"},{"phenoTypeId":13408,"phenoTypeName":"Nausea","percentRanges":"-"},{"phenoTypeId":3874,"phenoTypeName":"Pancreatitis","percentRanges":"-"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","percentRanges":"-"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Familial_chylomicronemia_syndrome"}